Startups
2023
1-10 Employees
Avocet Bio GmbHAvocet Bio is pioneering a revolutionary antiviral approach using CRISPR-Cas13 technology to combat rapidly mutating RNA viruses. Our modular platform precisely targets and degrades viral RNA, providing broad-spectrum protection while minimizing resistance and side effects.
By leveraging tailored delivery solutions, such as inhalable formulations, we aim to transform the global response to viral outbreaks, reducing disease severity, alleviating healthcare burdens, and strengthening public health resilience.
Currently, efforts are made to expand the platform technology to other RNA viruses or to RNA modulation in disease. Our solution represents an advancement in antiviral and RNA-modulating therapeutics, thereby enhancing public health resilience - a biotech company that will make an impact!
By leveraging tailored delivery solutions, such as inhalable formulations, we aim to transform the global response to viral outbreaks, reducing disease severity, alleviating healthcare burdens, and strengthening public health resilience.
Currently, efforts are made to expand the platform technology to other RNA viruses or to RNA modulation in disease. Our solution represents an advancement in antiviral and RNA-modulating therapeutics, thereby enhancing public health resilience - a biotech company that will make an impact!
Address
Annastraße 27, 37075 Göttingen, Germany
Commercial Register
GmbH
HRB206984
Finance Data
Startup Center
Leipzig, Germany
SPRIND
Further information
SDGs (Sustainable Development Goals)